Phospholipase Cγ1 Mediates Intima Formation Through Akt-Notch1 Signaling Independent of the Phospholipase Activity

J Am Heart Assoc. 2017 Jul 11;6(7):e005537. doi: 10.1161/JAHA.117.005537.

Abstract

Background: Vascular smooth muscle cell proliferation, migration, and dedifferentiation are critical for vascular diseases. Recently, it was demonstrated that Notch receptors have opposing effects on intima formation after vessel injury. Therefore, it is important to investigate the specific regulatory pathways that activate the different Notch receptors.

Methods and results: There was a time- and dose-dependent activation of Notch1 by angiotensin II and platelet-derived growth factor in vascular smooth muscle cells. When phospholipase Cγ1 (PLCγ1) expression was reduced by small interfering RNA, Notch1 activation and Hey2 expression (Notch target gene) induced by angiotensin II or platelet-derived growth factor were remarkably inhibited, while Notch2 degradation was not affected. Mechanistically, we observed an association of PLCγ1 and Akt, which increased after angiotensin II or platelet-derived growth factor stimulation. PLCγ1 knockdown significantly inhibited Akt activation. Importantly, PLCγ1 phospholipase site mutation (no phospholipase activity) did not affect Akt activation. Furthermore, PLCγ1 depletion inhibited platelet-derived growth factor-induced vascular smooth muscle cell proliferation, migration, and dedifferentiation, while it increased apoptosis. In vivo, PLCγ1 and control small interfering RNA were delivered periadventitially in pluronic gel and complete carotid artery ligation was performed. Morphometric analysis 21 days after ligation demonstrated that PLCγ1 small interfering RNA robustly attenuated intima area and intima/media ratio compared with the control group.

Conclusions: PLCγ1-Akt-mediated Notch1 signaling is crucial for intima formation. This effect is attributable to PLCγ1-Akt interaction but not PLCγ1 phospholipase activity. Specific inhibition of the PLCγ1 and Akt interaction will be a promising therapeutic strategy for preventing vascular remodeling.

Keywords: Akt; Notch1; intima formation; phospholipase Cγ1; vascular smooth muscle cell.

MeSH terms

  • Angiotensin II / pharmacology
  • Animals
  • Apoptosis
  • Carotid Artery Injuries / enzymology*
  • Carotid Artery Injuries / genetics
  • Carotid Artery Injuries / pathology
  • Cell Dedifferentiation
  • Cell Movement
  • Cell Proliferation
  • Cells, Cultured
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Male
  • Mice, Inbred C57BL
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / enzymology*
  • Muscle, Smooth, Vascular / pathology
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / enzymology*
  • Myocytes, Smooth Muscle / pathology
  • Neointima*
  • Phospholipase C gamma / genetics
  • Phospholipase C gamma / metabolism*
  • Phosphorylation
  • Platelet-Derived Growth Factor / pharmacology
  • Proto-Oncogene Proteins c-akt / metabolism*
  • RNA Interference
  • Rats
  • Receptor, Notch1 / metabolism*
  • Signal Transduction* / drug effects
  • Time Factors
  • Transfection
  • Vascular Remodeling

Substances

  • Notch1 protein, mouse
  • Notch1 protein, rat
  • Platelet-Derived Growth Factor
  • Receptor, Notch1
  • Angiotensin II
  • Proto-Oncogene Proteins c-akt
  • Phospholipase C gamma
  • Plcg1 protein, mouse
  • phospholipase Cgamma1, rat